METTL3 can also promote the progression of bladder cancer through both the NF-κB and MYC signaling networks since AFF4, IKBKB, and p65 as well as MYC transcripts are methylated and stabilized by METTL3 [90]. The gene discussed is MYC; the disease is urinary bladder carcinoma.